ABPI responds to Avastin case judgment

The Court has today made a judgment on the use of Avastin to treat a condition called wet age-related macular degeneration (wet AMD).

ABPI responds to Dr Ben Goldacre research on clinical trial transparency

The ABPI has responded to BMJ research into compliance with reporting the results of clinical trials. 

;